Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51) 51
humans (38) 38
cancer (34) 34
pharmacology & pharmacy (24) 24
animals (18) 18
drug resistance (17) 17
nanoparticles (17) 17
apoptosis (15) 15
chemotherapy (14) 14
overcome multidrug-resistance (14) 14
review (14) 14
drug delivery systems (13) 13
neoplasms - drug therapy (13) 13
nanoscience & nanotechnology (12) 12
oncology (12) 12
overcome drug-resistance (12) 12
antineoplastic agents - pharmacology (11) 11
cancer therapies (11) 11
health aspects (11) 11
tumors (11) 11
biochemistry & molecular biology (10) 10
cell biology (10) 10
hypoxia (10) 10
in-vitro (10) 10
cell line, tumor (9) 9
drugs (9) 9
in-vivo (9) 9
multiple myeloma (9) 9
breast-cancer (8) 8
care and treatment (8) 8
drug therapy (8) 8
metastasis (8) 8
mice (8) 8
resistance (8) 8
tumor microenvironment (8) 8
antineoplastic agents - therapeutic use (7) 7
apoptosis - drug effects (7) 7
bortezomib (7) 7
co-delivery (7) 7
mesoporous silica nanoparticles (7) 7
nf-kappa-b (7) 7
overcome tumor hypoxia (7) 7
proteins (7) 7
analysis (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
cell cycle (6) 6
chemistry, multidisciplinary (6) 6
drug resistance, neoplasm (6) 6
gold nanoparticles (6) 6
male (6) 6
materials science, multidisciplinary (6) 6
neoplasms - pathology (6) 6
overcome (6) 6
overcomes bortezomib resistance (6) 6
overcomes drug-resistance (6) 6
small-molecule inhibitor (6) 6
vehicles (6) 6
article (5) 5
autophagy (5) 5
cell survival (5) 5
delivery (5) 5
development and progression (5) 5
drug-delivery (5) 5
drug-resistance (5) 5
female (5) 5
genes (5) 5
hematology (5) 5
kinases (5) 5
mitochondria (5) 5
mortality (5) 5
multidrug resistance (5) 5
multiple myeloma - drug therapy (5) 5
nanomedicine (5) 5
nanopartikel (5) 5
physiological aspects (5) 5
proteasome inhibitors (5) 5
radiation therapy (5) 5
radiotherapy (5) 5
research (5) 5
signal transduction - drug effects (5) 5
solid lipid nanoparticles (5) 5
therapeutics (5) 5
tumor (5) 5
ubiquitination (5) 5
angiogenesis (4) 4
antineoplastic agents - administration & dosage (4) 4
biochemistry, general (4) 4
biomedicine (4) 4
biotechnology (4) 4
bone marrow (4) 4
cell proliferation - drug effects (4) 4
cell-death (4) 4
cells (4) 4
chemistry (4) 4
deoxyribonucleic acid--dna (4) 4
down-regulation (4) 4
drug delivery (4) 4
endocrinology & metabolism (4) 4
er stress (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy
by Zhang, Rui and Feng, Liangzhu and Dong, Ziliang and Wang, Yucai and Wang, Li and Liang, Chao and Chen, Jiawen and Chen, Qian and Ma, Qingxi and Liu, Zhuang
Biomaterials, ISSN 0142-9612, 04/2018, Volume 162, pp. 123 - 131
Starvation therapy to slow down the tumor growth by cutting off its energy supply has been proposed to be an alternative therapeutic strategy for cancer... 
Liposome | Glucose oxidase | Starvation therapy | AQ4N | Tumor hypoxia-activated therapy | MATERIALS SCIENCE, BIOMATERIALS | PHOTODYNAMIC THERAPY | ENGINEERING, BIOMEDICAL | CELL METABOLISM | AGENT | NANOPARTICLES | PRODRUGS | IN-VIVO | RESISTANCE | RADIOTHERAPY | OVERCOME TUMOR HYPOXIA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Perfluorocarbon‐Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near‐Infrared Light to Enhance the Radiotherapy of Cancer
by Song, Guosheng and Liang, Chao and Yi, Xuan and Zhao, Qi and Cheng, Liang and Yang, Kai and Liu, Zhuang
Advanced Materials, ISSN 0935-9648, 04/2016, Volume 28, Issue 14, pp. 2716 - 2723
Hollow Bi2Se3 nanoparticles prepared by a cation exchange method are loaded with perfluorocarbon as an oxygen carrier. With these nanoparticles, a promising... 
overcome tumor hypoxia | enhanced radiation therapy | oxygen carries | hollow structures | cation exchange | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | CATION-EXCHANGE | SHELL | PHOTODYNAMIC THERAPY | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOCRYSTALS | NANOMATERIALS | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | PHOTOTHERMAL ABLATION | HYPOXIA | CHEMISTRY, MULTIDISCIPLINARY | RADIATION-THERAPY | NANOTHERANOSTICS | DNA Damage - drug effects | Fluorocarbons - chemistry | Cell Survival - drug effects | Microscopy, Electron, Transmission | Metal Nanoparticles - chemistry | Polyethylene Glycols - chemistry | Cell Survival - radiation effects | Organoselenium Compounds - chemistry | Oxygen - metabolism | Transplantation, Homologous | Neoplasms - drug therapy | Bismuth - chemistry | Metal Nanoparticles - toxicity | Animals | Infrared Rays | Oxygen - chemistry | Cell Line, Tumor | Neoplasms - radiotherapy | Mice | Neoplasms - pathology | DNA Damage - radiation effects | Metal Nanoparticles - ultrastructure | Radiotherapy | Perfluorocarbons | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Modulation of Intracellular Oxygen Pressure by Dual‐Drug Nanoparticles to Enhance Photodynamic Therapy
by Fan, Ya‐Tong and Zhou, Tian‐Jiao and Cui, Peng‐Fei and He, Yu‐Jing and Chang, Xin and Xing, Lei and Jiang, Hu‐Lin
Advanced Functional Materials, ISSN 1616-301X, 03/2019, Volume 29, Issue 10, pp. 1806708 - n/a
Oxygen plays an essential role in the photodynamic therapy (PDT) of cancer. However, hypoxia inside tumors severely attenuates the therapeutic effect of PDT.... 
hypoxia | atovaquone | oxygen consumption rate | photodynamic therapy | verteporfin | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | TUMOR HYPOXIA | STABILITY | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CANCER | CHEMISTRY, MULTIDISCIPLINARY | OVERCOME | DELIVERY | PEG | SINGLET OXYGEN | LIMITATION | Nanoparticles | Verteporfin | Photochemotherapy | Cancer | Mitochondria | Drug delivery systems | Photodynamic therapy | Oxygen consumption | Hypoxia | In vivo methods and tests | Oxygen content | Tumors | Anticancer properties
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Au nanoparticles with enzyme-mimicking activity-ornamented ZIF-8 for highly efficient photodynamic therapy
by Ma, Yin-Chu and Zhu, Yan-Hua and Tang, Xin-Feng and Hang, Li-Feng and Jiang, Wei and Li, Min and Khan, Malik Ihsanullah and You, Ye-Zi and Wang, Yu-Cai
Biomaterials Science, ISSN 2047-4830, 07/2019, Volume 7, Issue 7, pp. 2740 - 2748
The tumor hypoxic microenvironment (THME) has a profound impact on tumor progression, and modulation of the THME has become an essential strategy to promote... 
GOLD NANOPARTICLES | PEROXIDASE | MATERIALS SCIENCE, BIOMATERIALS | METAL-ORGANIC-FRAMEWORK | CISPLATIN | OXIDASE | RESISTANCE | CATALYST | OVERCOME TUMOR HYPOXIA | CANCER | DELIVERY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cancer Therapy: Perfluorocarbon‐Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near‐Infrared Light to Enhance the Radiotherapy of Cancer (Adv. Mater. 14/2016)
by Song, Guosheng and Liang, Chao and Yi, Xuan and Zhao, Qi and Cheng, Liang and Yang, Kai and Liu, Zhuang
Advanced Materials, ISSN 0935-9648, 04/2016, Volume 28, Issue 14, pp. 2654 - 2654
Hollow Bi2Se3 nanoparticles prepared by a cation exchange method are loaded with perfluorocarbon as an oxygen carrier. With those nanoparticles, a new concept... 
overcome tumor hypoxia | enhanced radiation therapy | oxygen carries | hollow structures | cation exchange | Antimitotic agents | Perfluorocarbons | Care and treatment | Radiotherapy | Antineoplastic agents | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine
by Jiang, Xing and Zhang, Baoli and Zhou, Zaigang and Meng, Lingtong and Sun, Zhiling and Xu, Yun and Xu, Qiuping and Yuan, Ahu and Yu, Lixia and Qian, Hanqing and Wu, Jinhui and Hu, Yiqiao and Liu, Baorui
Drug Delivery, ISSN 1071-7544, 01/2017, Volume 24, Issue 1, pp. 1419 - 1428
Paclitaxel (PTX) is widely used as a radiosensitizer in the clinical treatment of cancer. However, the efficacy of chemoradiotherapy is limited by the... 
paclitaxel | hypoxia | liposomes | Chemoradiotherapy | perfluorotributylamine | PERFLUOROCARBON | CANCER-THERAPY | RADIATION-THERAPY | DELIVERY | OXYGEN | NANOPARTICLES | RESISTANCE | PHARMACOLOGY & PHARMACY | ALBUMIN | OVERCOME TUMOR HYPOXIA | EMULSIONS | Fluorocarbons - chemistry | Paclitaxel - chemistry | Liposomes | Humans | Hypoxia | Cell cycle | Radiation therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Au-PLGA Hybrid Nanoparticles with Catalase-Mimicking and near-Infrared Photothermal Activities for Photoacoustic Imaging-Guided Cancer Therapy
by Xi, Juqun and Wang, Wenjuan and Da, Lanyue and Zhang, Jingjing and Fan, Lei and Gao, Lizeng
ACS Biomaterials Science & Engineering, ISSN 2373-9878, 03/2018, Volume 4, Issue 3, pp. 1083 - 1091
Imaging-guided diagnosis and therapy has been highlighted in the area of nanomedicines. However, integrating multiple functions with high performance in one... 
GOLD NANOPARTICLES | MATERIALS SCIENCE, BIOMATERIALS | DRUG-DELIVERY | LIGHT | NANORODS | COMBINATION | Au-PLGA hybrid nanoparticles | catalase-mimicking activity chemo/photothermal therapy | PEROXIDASE | photoacoustic imaging | NANOSHELLS | IN-VIVO | OVERCOME TUMOR HYPOXIA | LIPOSOMES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Advanced nanomaterials targeting hypoxia to enhance radiotherapy
by Li, Jia and Li, Jia and Shang, Wenting and Li, Yong and Li, Yong and Fu, Sirui and Fu, Sirui and Tian, Jie and Tian, Jie and Lu, Ligong and Lu, Ligong
International journal of nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 5925 - 5936
Hypoxia within solid tumors is often responsible for the failure of radiotherapy. The development of hypoxia-targeting nanomaterials - aimed at enhancing the... 
hypoxia-inducible factor 1 | radiotherapy | hypoxia | nanomaterials | GOLD NANOPARTICLES | OXYGEN DELIVERY | POSTOPERATIVE CHEMORADIOTHERAPY | MULTIFUNCTIONAL NANOTHERANOSTICS | NANOSCIENCE & NANOTECHNOLOGY | BREAST-CANCER CELLS | RECTAL-CANCER | inducible factor 1 | CLINICAL-APPLICATIONS | IN-VIVO | PHARMACOLOGY & PHARMACY | OVERCOME TUMOR HYPOXIA | DRUG-DELIVERY SYSTEMS | Drugs | Ionizing radiation | Drug delivery systems | Radiotherapy | Perflubron | Vehicles | Tumors | Perfluorocarbons | Free radicals | Medical imaging | Laboratories | Brain cancer | Nanomaterials | Metastasis | Radiation therapy | Cancer therapies | Nanoparticles | Chemotherapy | X rays | Polyethylene glycol | Hypoxia | Deoxyribonucleic acid--DNA | nanoparticle | clinical translation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
by Talekar, Meghna and Tran, Thanh-Huyen and Amiji, Mansoor
The AAPS Journal, ISSN 1550-7416, 7/2015, Volume 17, Issue 4, pp. 813 - 827
With the advent of novel and personalized therapeutic approaches for cancer and inflammatory diseases, there is a growing demand for designing delivery systems... 
Biochemistry, general | Biotechnology | hypoxia | multidrug resistance | Biomedicine | targeted biological therapies | Pharmacy | inflammatory disease | macrophage repolarization | Pharmacology/Toxicology | aerobic glycolysis | RHEUMATOID-ARTHRITIS | COLLAGEN-INDUCED ARTHRITIS | GENE DELIVERY | DRUG-DELIVERY | OVERCOME MULTIDRUG-RESISTANCE | BOWEL-DISEASE | HUMAN PROSTATE-CANCER | SMALL INTERFERING RNA | PHARMACOLOGY & PHARMACY | MACROPHAGE POLARIZATION | ENDOTHELIAL GROWTH-FACTOR | Inflammation - pathology | Anti-Inflammatory Agents - pharmacology | Humans | Translational Medical Research | Tumor Microenvironment | Antineoplastic Agents - administration & dosage | Drug Delivery Systems | Neoplasms - drug therapy | Nanoparticles | Macrophages - metabolism | Animals | Inflammation - drug therapy | Anti-Inflammatory Agents - administration & dosage | Antineoplastic Agents - pharmacology | Neoplasms - pathology | Drugs | Glucose metabolism | Chemotherapy | Drugstores | Drug therapy | Drug resistance | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice
by Zhao, Xiaojing and Chen, Qi and Li, Yusang and Tang, Hebin and Liu, Wei and Yang, Xiangliang
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 06/2015, Volume 93, pp. 27 - 36
At present, the treatment of hepatocellular carcinoma (HCC) is an international problem. The delivery of a chemotherapeutic agent and chemosensitizer using... 
Co-delivery lipid nanoparticles | Multidrug resistance | Tumor growth inhibition | Hepatocellular carcinoma | Curcumin | Synergistic effect | Doxorubicin | MOLECULAR-MECHANISM | CANCER-CELLS | THERAPEUTICS | APOPTOSIS | OVERCOME MULTIDRUG-RESISTANCE | DRUG-RESISTANCE | HYPOXIA | CHEMOTHERAPY | HEPATOCARCINOGENESIS | PHARMACOLOGY & PHARMACY | CHEMORESISTANCE | Carcinoma, Hepatocellular - chemically induced | Apoptosis - drug effects | Curcumin - chemistry | Humans | Gene Expression Regulation, Neoplastic | Liver Neoplasms, Experimental - chemically induced | Neovascularization, Pathologic | Drug Resistance, Neoplasm | Male | Doxorubicin - chemistry | Curcumin - administration & dosage | Drug Carriers | Dose-Response Relationship, Drug | Nanoparticles | Liver Neoplasms, Experimental - metabolism | Antineoplastic Agents, Phytogenic - administration & dosage | Lipids - chemistry | Carcinoma, Hepatocellular - drug therapy | Antibiotics, Antineoplastic - chemistry | Time Factors | Carcinoma, Hepatocellular - genetics | Diethylnitrosamine | Biomarkers, Tumor - metabolism | Liver Neoplasms, Experimental - genetics | Liver Neoplasms, Experimental - pathology | Nanomedicine | Doxorubicin - administration & dosage | Solubility | Antineoplastic Agents, Phytogenic - chemistry | Technology, Pharmaceutical - methods | Chemistry, Pharmaceutical | Antibiotics, Antineoplastic - administration & dosage | Drug Synergism | Particle Size | Animals | Liver Neoplasms, Experimental - drug therapy | Carcinoma, Hepatocellular - pathology | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Mice | Delayed-Action Preparations | Drug Combinations | Carcinoma, Hepatocellular - metabolism | Anthracyclines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation
by Li, Wei and Qiu, Yunhan and Hao, Ji and Zhao, Chi and Deng, Xukun and Shu, Guangwen
Food and Chemical Toxicology, ISSN 0278-6915, 11/2018, Volume 121, pp. 156 - 165
Dauricine (Dau) is a natural alkaloid exhibiting anti-proliferative activity against several different types of malignant cell. However, effects of Dau on... 
MiR-199a | Chemosensitivity | Glycolysis | Hepatocellular carcinoma | Dauricine | APOPTOSIS | HEXOKINASE 2 | FOOD SCIENCE & TECHNOLOGY | PROLIFERATION | OVERCOMES SORAFENIB RESISTANCE | HYPOXIA | SUPPRESSION | CANCER STEM-CELLS | IN-VITRO | METABOLISM | LIVER | TOXICOLOGY | Tetrahydroisoquinolines - pharmacology | Aerobiosis | Liver Neoplasms - genetics | Humans | Liver Neoplasms - drug therapy | Oxidative Phosphorylation | MicroRNAs - metabolism | Antineoplastic Agents - therapeutic use | Glycolysis - drug effects | Kinesin - metabolism | Up-Regulation - drug effects | Animals | Carcinoma, Hepatocellular - drug therapy | Carrier Proteins - metabolism | Mice, Nude | Thyroid Hormones - metabolism | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - metabolism | Cell Line, Tumor | Membrane Proteins - metabolism | Mice | Benzylisoquinolines - pharmacology | Carcinoma, Hepatocellular - metabolism | Drug Resistance, Neoplasm - drug effects | Glucose metabolism | Chemotherapy | Chemical tests and reagents | Analysis | Hepatoma | Glucose | Dextrose | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Fenton Reaction-Assisted Photodynamic Therapy for Cancer with Multifunctional Magnetic Nanoparticles
by Hou, HB and Huang, XH and Wei, GQ and Xu, FN and Wang, Y and Zhou, SB
ACS APPLIED MATERIALS & INTERFACES, ISSN 1944-8244, 08/2019, Volume 11, Issue 33, pp. 29579 - 29592
Tumor hypoxia and the short half-life of reactive oxygen species (ROS) with small diffusion distance have greatly limited the therapeutic effect of... 
photodynamic therapy | MEMBRANE | MATERIALS SCIENCE, MULTIDISCIPLINARY | MITOCHONDRIA | NANOSCIENCE & NANOTECHNOLOGY | MECHANISMS | COMBINED CHEMOTHERAPY | MICROBUBBLES | COMBINATION | OVERCOME | DELIVERY | magnetic resonance imaging nanoparticle | RESISTANCE | Fenton reaction | EFFICIENT | mitochondrial targeting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Current Applications of Nanoemulsions in Cancer Therapeutics
by Sanchez-Lopez, E and Guerra, M and Dias-Ferreira, J and Lopez-Machado, A and Ettcheto, M and Cano, A and Espina, M and Camins, A and Garcia, ML and Souto, EB
NANOMATERIALS, ISSN 2079-4991, 06/2019, Volume 9, Issue 6, p. 821
Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly... 
GOLD NANOPARTICLES | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | targeted delivery | OVERCOME MULTIDRUG-RESISTANCE | NANOSCIENCE & NANOTECHNOLOGY | SOLID LIPID NANOPARTICLES | BREAST-CANCER | LUNG-CANCER | ANTICANCER ACTIVITY | IN-VITRO | cancer | INORGANIC NANOPARTICLES | multifunctional nanoemulsions | Drugs | Drug delivery systems | Toxicity | Lipids | Metastasis | Hydrophobicity | Cancer therapies | Cell surface | Nanoparticles | Vascular endothelial growth factor | Pharmaceutical sciences | Formulations | Antigens | Tumor cells | Multidrug resistance | Organs | Solubility | Nanoemulsions | Permeability | Pharmacy | Hypoxia | Charged particles | Prostate | Cell migration | Cancer | Tumors | Càncer | Nanopartícules | Experimental pharmacology | Sistemes d'alliberament de medicaments | Farmacologia experimental
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Molecular and cellular effects of multi‐targeted cyclin‐dependent kinase inhibition in myeloma: biological and clinical implications
by McMillin, Douglas W and Delmore, Jake and Negri, Joseph and Buon, Leutz and Jacobs, Hannah M and Laubach, Jacob and Jakubikova, Jana and Ooi, Melissa and Hayden, Patrick and Schlossman, Robert and Munshi, Nikhil C and Lengauer, Christoph and Richardson, Paul G and Anderson, Kenneth C and Mitsiades, Constantine S
British Journal of Haematology, ISSN 0007-1048, 02/2011, Volume 152, Issue 4, pp. 420 - 432
Summary Cell cycle regulators, such as cyclin‐dependent kinases (CDKs), are appealing targets for multiple myeloma (MM) therapy given the increased... 
microenvironment | kinase inhibitor | cancer | myeloma | cyclin‐dependent kinases | Microenvironment | Myeloma | Kinase inhibitor | Cyclin-dependent kinases | Cancer | APOPTOSIS | REFRACTORY MULTIPLE-MYELOMA | SELICICLIB CYC202 | PLASMA-CELL | LENALIDOMIDE PLUS DEXAMETHASONE | DOWN-REGULATION | OVERCOMES DRUG-RESISTANCE | CDK INHIBITOR | R-ROSCOVITINE | cyclin-dependent kinases | HEMATOLOGY | TRANSCRIPTIONAL REGULATION | Cyclin-Dependent Kinases - metabolism | Apoptosis - drug effects | Coculture Techniques | Humans | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Drug Interactions | Transcription, Genetic | Antineoplastic Agents - pharmacology | Cyclin-Dependent Kinases - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Multiple Myeloma - enzymology | Cell Survival - drug effects | Bortezomib | Treatment Outcome | Down-Regulation - drug effects | Multiple Myeloma - pathology | Signal Transduction - drug effects | Survival Analysis | Cytokines - antagonists & inhibitors | Cell Cycle - drug effects | Stromal Cells - physiology | Cytokines - pharmacology | Drug Combinations | Multiple Myeloma - genetics | Drug Screening Assays, Antitumor | Medical colleges | Cell death | Oncology, Experimental | Multiple myeloma | Stem cells | Research | DNA binding proteins | Drug resistance | Phosphotransferases | Tumors | Transcription factors | Cell survival | Cytokines | Complications | Hypoxia-inducible factor 1 alpha | Stroma | Myc protein | Cyclin-dependent kinase 5 | Cyclin-dependent kinase | Cyclin-dependent kinase 2 | Interferon regulatory factor 4 | Cell cycle | Bone marrow | Tumorigenesis | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Can Gene Therapy Overcome the Problem of Hypoxia in Radiotherapy?
by OLGA GRECO and ADAM V. PATTERSON and GABI U. DACHS and School of Pharmacy and Pharmaceutical Sciences and Gray Laboratory Cancer Research Trust and Mount Vernon Hospital and University of Manchester
JOURNAL OF RADIATION RESEARCH, ISSN 0449-3060, 2000, Volume 41, Issue 3, pp. 201 - 212
Studies have shown that reduced oxygen tension (hypoxia) in solid tumours adversely affects the outcome of radiotherapy. Despite being an independent... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Proteasome inhibitors and modulators of angiogenesis in Multiple Myeloma
by Ferrarini, M and Ferrero, E
Current Medicinal Chemistry, ISSN 0929-8673, 12/2011, Volume 18, Issue 34, pp. 5185 - 5195
Survival of patients affected by Multiple Myeloma (MM), a B-cell tumor of malignant plasma cells, has dramatically improved, owing to the recent introduction... 
Immunomodulatory drugs | Angiogenesis | Bone marrow microenvironment | Hypoxia | Anti-angiogenic therapies | Proteasome inhibitors | Multiple Myeloma | PROGENITOR CELLS | hypoxia | CHEMISTRY, MEDICINAL | angiogenesis | BIOCHEMISTRY & MOLECULAR BIOLOGY | DELTA T-CELLS | OVERCOMES DRUG-RESISTANCE | Bone Marrow microenvironment | MICROVESSEL DENSITY | BONE-MARROW ANGIOGENESIS | UNFOLDED PROTEIN RESPONSE | anti-angiogenic therapies | CLASS-I | UNDETERMINED SIGNIFICANCE | PHARMACOLOGY & PHARMACY | MONOCLONAL GAMMOPATHY | Proteasome Inhibitors | ENDOTHELIAL GROWTH-FACTOR | Multiple Myeloma - drug therapy | Animals | Neovascularization, Pathologic - drug therapy | Humans | Angiogenesis Inhibitors - therapeutic use | Multiple Myeloma - immunology | Multiple Myeloma - blood supply | Multiple Myeloma - enzymology | Enzyme Inhibitors - therapeutic use | Immunologic Factors - therapeutic use | Neovascularization, Pathologic - pathology
Journal Article
Details down arrow
17. Full Text Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes
by Samson, Jenny Mae and Ravindran Menon, Dinoop and Smith, Derek E and Baird, Erika and Kitano, Takayuki and Gao, Dexiang and Tan, Aik-Choon and Fujita, Mayumi
Chemico-Biological Interactions, ISSN 0009-2797, 12/2019, Volume 314, p. 108822
Aldehyde dehydrogenase (ALDH) activity is not only a valuable marker for cancer cells with stem-like features, but also plays a vital role in drug resistance... 
ALDH1A3 | GSEA | Melanoma patient prognosis | BRAF/MEK inhibitor response | ALDH1A1 | DNA METHYLATION | ALDEHYDE DEHYDROGENASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACQUIRED-RESISTANCE | BRAF | MECHANISMS | OVERCOME | CANCER STEM-CELLS | INTERFERON-ALPHA | PATHWAY | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PROGNOSTIC-SIGNIFICANCE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights